AJRCCM: 100-YearAnniversary.The Shifting Landscape for Lung Cancer: Past, Present, and Future-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

AJRCCM: 100-YearAnniversary.The Shifting Landscape for Lung Cancer: Past, Present, and Future

Published:2017-05 Issue:9 Volume:195 Page:1150-1160
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Vachani Anil¹,Sequist Lecia V.²,Spira Avrum³

Affiliation:

1. Division of Pulmonary, Allergy, and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania

2. Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; and

3. Section of Computational Biomedicine, Department of Medicine, Boston University Medical Center, Boston, Massachusetts

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Link

http://www.atsjournals.org/doi/pdf/10.1164/rccm.201702-0433CI

Reference101 articles.

1. Improving lung cancer survival; time to move on

2. Smoking and Carcinoma of the Lung

3. The Health Effects of Electronic Cigarettes

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rabenosyn-5 suppresses non-small cell lung cancer metastasis via inhibiting CDC42 activity;Cancer Gene Therapy;2024-07-29

2. Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment;Cancer Letters;2024-03

3. Yi Qi Chu Tan Formula (YQCTF) inhibited the progress of lung cancer via regulating tumor-associated neutrophil: An integrated study of network pharmacology, proteomics and pharmacodynamics;Journal of Ethnopharmacology;2024-01

4. Lung Cancer;Biomedical Aspects of Solid Cancers;2024

5. Development of a multi-feature-combined model: proof-of-concept with application to local failure prediction of post-SBRT or surgery early-stage NSCLC patients;Frontiers in Oncology;2023-09-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3